NFE2L2 and pancreatic neoplasm: Reduces nuclear accumulation of Nrf2 in pancreatic cancer cells and sensitizes them to anticancer drugs and TRAIL via Nrf2 inhibition [76]. Enhances response to chemotherapy in vivo [76]